Seham Skah

640 citations
11 papers · 498 indexed · h-index 8
Topics
Wnt/β-catenin signaling in development and cancer (3 papers)Acute Lymphoblastic Leukemia research (2 papers)Genetics and Neurodevelopmental Disorders (2 papers)
Partner nations
FranceNorwayBelgium

In The Last Decade

Seham Skah

10 papers receiving 495 citations

Peers

Seham Skah
Comparison fields: 5 of 63
  • Molecular Biology 232
  • Endocrinology, Diabetes and Metabolism 201
  • Genetics 127
  • Surgery 106
  • Oncology 97
Replace Sushela Chaidarun with:
Sushela Chaidarun United States
Ferdous M. Barlaskar United States
Milena Doroszko Finland
Thomas Hoelting Germany
Yael Bar Israel
Susanne Lingelbach Germany
Bhakta R. Dey United States
Carey Welsh United States
María Roqué Argentina
Catherine McCaig United Kingdom
Seham Skah relative to Sushela Chaidarun United States Sushela Chaidarun's profile →
Citations per field
00.5×4.1×
Sushela Chaidarun · 1×
Citations per year

Countries citing papers authored by Seham Skah

Since Specialization
Citations

This map shows the geographic impact of Seham Skah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seham Skah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seham Skah more than expected).

Fields of papers citing papers by Seham Skah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seham Skah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seham Skah. The network helps show where Seham Skah may publish in the future.

Co-authorship network of co-authors of Seham Skah

This figure shows the co-authorship network connecting the top 25 collaborators of Seham Skah. A scholar is included among the top collaborators of Seham Skah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seham Skah. Seham Skah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 7
3 19
4 32
5 1
6 73
7 21
8 148
9 39
10 94
11 64

About Seham Skah

Seham Skah is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Cancer Research, having authored 11 papers that have together received 498 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Genetics and Neurodevelopmental Disorders (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (201 citations), Cancer Research (76 citations) and Genetics (127 citations). Seham Skah has collaborated with scholars based in France, Norway and Belgium. Frequent co-authors include Michelina Plateroti, Julien Nadjar, M Sirakov, Jacques Samarut, Amélie Rezza, Colette Roche, Heidi Kiil Blomhoff, Ellen Ruud, Sheerazed Boulkroun and Annabel Berthon. Their work appears in journals such as Gastroenterology, Journal of Cell Science and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026